Events2Join

The Private Equity Landscape In Urology Is Expanding


The Private Equity Landscape in Urology Is Expanding

Since Audax Group's initial investment in Chesapeake Urology in August 2016, highly experienced multi-site healthcare services private equity. (PE) investors ...

The Private Equity Landscape In Urology Is Expanding

The private equity landscape in urology is expanding.

What private equity's growing investment in urology practices means ...

Private equity is increasing its influence in urology. Here's how oncology manufacturers can navigate this evolving market.

mp57-14 the immediate effects of private equity ... - Journal of Urology

In the year following acquisition of urology practices, private equity did not increase prostate cancer spending, the use of treatment or ...

Urology Private Equity – Market Update - Physician Growth Partners

In recent years urology has grown as an attractive specialty target for private equity investors. With a historically fragmented landscape, large PE-backed ...

AUA ADVOCACY Point/Counterpoint: Private Equity in Urology

Urologists in independent practice who want to grow their practices in the face of decreasing third-party payments and increasing regulatory ...

Urology Opens the Door to Private Equity and Consolidation

There is almost unlimited potential for financial growth in urology because of rising patient demand. “Urology is a surgical subspecialty ...

Private equity-backed urology group continues its expansion into ...

A private equity-backed urology group continues its expansion into interventional radiology with the opening of a new center.

Urology Private Equity – White Paper - Physician Growth Partners

The current urology landscape includes six private equity backed urology groups, along with one oncology focused network.

Examining the Impact of Private Equity Investment in Urology

... (PE)-backed urology platforms, which differ from prior consolidations in their scale and market power ... PE had increasing Medicare ...

The Role of Private Equity in Urology - YouTube

Comments · Private Equity M&A – Understanding the Deal Process · Deepak A. · David Rubenstein Interview: Wharton Private Equity and Venture Capital ...

Urology practices' growing role in oncology: Three trends to watch

1. Growing oncology care capabilities and infrastructure: · 2. Oncology market evolution · 3. Private equity's growing influence and practice ...

Urological Care Industry Sector Spotlight | Winter 2024

PE-affiliated urologists, leaves significant whitespace for expansion ... Private Limited, registered as an investment adviser with the.

Private equity-backed urology practice enters interventional ...

A private equity-backed urology practice is partnering with experts in interventional radiology to launch a new IR-focused facility in the Midwest.

Private Equity Entry In Urology: Acquisition Trends, Market Analysis ...

Private equity (PE) firms have recently begun acquiring urology practices, yet little is known about the scale and impact of these acquisitions.

Acquisition of urology practices by private equity firms and ... - NCBI

Between 2017 and 2020, 181 urologists were in a urology practice acquired by private equity with MIPS data available the year before and after ...

Private equity acquisition affects urologists' Medicare payment ...

"Private equity aims to strategically increase the value of a practice by reducing costs or expanding revenue, with the goal of selling it for a profit," Dr.

Private Equity and Urology - Solaris Health

Independent urology practices are under increasing competitive pressure, as hospitals seek to acquire more physicians to strengthen their own positions in the ...

The immediate effects of private equity acquisition of urology ...

In our national study, private equity acquisition did not lead to an increase in price standardized prostate cancer spending, a global measure ...

The 2024 Outlook for Private Equity in US Health Care|BCG

As the market recovers in 2024, multiple trends affecting providers, payers, pharma, medtech, and life science tools will shape how private equity investors ...